Literature DB >> 19711927

Application of cross-conjugated heteroaromatic betaines to the synthesis of the schizozygane alkaloid (+/-)-strempeliopine.

Drew R Bobeck1, Hyoung Ik Lee, Andrew C Flick, Albert Padwa.   

Abstract

An efficient stereocontrolled route to the isoschizozygane alkaloid core has been developed utilizing an intramolecular 1,4-dipolar cycloaddition of a cross-conjugated heteroaromatic betaine. The resulting cycloadduct undergoes loss of COS, and further reduction delivers a 5a-azaacenaphthylene intermediate that was transformed into the isoschizozygane skeleton upon treatment with acid. A variation of this tactic was then employed for a synthesis of the hexacyclic framework of the shizozygane alkaloid (+/-)-strempeliopine. The key step of the synthesis corresponds to an intramolecular 1,4-dipolar cycloaddition of a heteroaromatic betaine across a tethered 4-((2-nitrophenyl)but-3-enyl) side chain. Catalytic reduction of the nitro group followed by reaction with NBS resulted in the formation of the required pentacyclic indoline framework of the target alkaloid. Closure of the final ring of the shizozygane skeleton was carried using an oxidative cyclization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711927     DOI: 10.1021/jo901336z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  A new cross-conjugated mesomeric betaine.

Authors:  Nivedita Sharma; Manjinder Kour; Raakhi Gupta; Raj K Bansal
Journal:  RSC Adv       Date:  2021-07-21       Impact factor: 4.036

2.  Total Synthesis of (-)-Strempeliopine.

Authors:  Xianhuang Zeng; Dale L Boger
Journal:  J Am Chem Soc       Date:  2021-07-29       Impact factor: 16.383

3.  Asymmetric [4 + 2] annulation of 5H-thiazol-4-ones with a chiral dipeptide-based Brønsted base catalyst.

Authors:  Bo Zhu; Shuai Qiu; Jiangtao Li; Michelle L Coote; Richmond Lee; Zhiyong Jiang
Journal:  Chem Sci       Date:  2016-06-09       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.